Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease
- 26 February 2020
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 189 (6), 1192-1203
- https://doi.org/10.1111/bjh.16519
Abstract
Patients with sickle cell disease (SCD) are at increased risk for neurocognitive impairments. While disease‐modifying treatment, such as hydroxycarbamide (hydroxyurea), may decrease this risk, it has not been systematically investigated in children with SCD. We screened neurocognitive functioning in 103 adolescents with SCD (16–17 years, 50% female) and compared outcomes between patients with a history of exposure to hydroxycarbamide (n = 12 HbSC/HbSβ+ thalassaemia; n = 52 HbSS/HbSβ0 thalassaemia) and those never treated with hydroxycarbamide (n = 31 HbSC/HbSβ+ thalassaemia; n = 8 HbSS/HbSβ0 thalassaemia). Demographic distributions were similar between the groups. After adjusting for socioeconomic status, the hydroxycarbamide group had significantly higher scores on nonverbal IQ (HbSC/HbSβ thalassaemia: P = 0·036, effect size [d] = 0·65), reaction speed (HbSS/HbSβ0 thalassaemia: P = 0·002, d = 1·70), sustained attention (HbSS/HbSβ0 thalassaemia: P = 0·014, d = 1·30), working memory (HbSC/HbSβ+ thalassaemia: P = 0·034, d = 0·71) and verbal memory (HbSC/HbSβ+ thalassaemia: P = 0·038, d = 0·84) when compared to those who did not receive hydroxycarbamide. In patients with HbSS/HbSβ0 thalassaemia, longer treatment duration with hydroxycarbamide was associated with better verbal memory (P = 0·009) and reading (P = 0·002). Markers of hydroxycarbamide effect, including higher fetal haemoglobin (HbF), higher mean corpuscular volume (MCV) and lower white blood cell count (WBC), were associated with better verbal fluency (HbF: P = 0·014, MCV: P = 0·006, WBC: P = 0·047) and reading (MCV: P = 0·021, WBC: P = 0·037). Cognitive impairment may be mitigated by exposure to hydroxycarbamide in adolescents with SCD.Keywords
Funding Information
- American Lebanese Syrian Associated Charities
This publication has 46 references indexed in Scilit:
- Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian childrenChild Neuropsychology, 2013
- Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)The Lancet, 2011
- Neurocognitive deficits in children with sickle cell disease: a comprehensive profilePediatric Blood & Cancer, 2010
- Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell AnemiaJAMA, 2010
- Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyureaPediatric Blood & Cancer, 2007
- Neurocognitive Sequelae of Pediatric Sickle Cell Disease: A Review of the LiteratureChild Neuropsychology, 2007
- The Association of Oral Hydroxyurea Therapy with Improved Cognitive Functioning in Sickle Cell DiseaseChild Neuropsychology, 2007
- Factors associated with lowered intelligence in homozygous sickle cell disease.Archives of Disease in Childhood, 1995
- Cognitive and Academic Functioning in Children With Sickle-Cell DiseaseJournal of Clinical Child Psychology, 1993
- Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with Sickle Cell DiseaseJournal of Chronic Diseases, 1985